Parexel to tap additional pharmacovigilance services with QSI acquisition

By Zachary Brennan contact

- Last updated on GMT

Parexel to tap additional pharmacovigilance services with QSI acquisition

Related tags: Clinical research services, Pharmacology

Global CRO Parexel has signed a definitive agreement to acquire privately-owned, Chandigarh, India-based Quantum Solutions India, a provider of specialized pharmacovigilance services. 

The acquisition is expected to close in early April, subject to the satisfaction of closing conditions. Financial details were not revealed though Parexel said the purchase will be funded with existing cash.  The impact of the acquisition on Parexel's FY 2015 revenue and earnings per share is not expected to be material. 

Established in 2004, QSI offers a range of pharmacovigilance services including individual case safety report processing, brand physician activities, affiliate support, aggregate report writing, literature reviews, and signal detection.  The company serves pharma, medical device and consumer clients and has approximately 900 employees.

A Parexel spokeswoman did not respond to a request for comment on whether Parexel would absorb all 900 of QSI’s employees though “additional details​” will be shared when the acquisition closes.

Josef von Rickenbach, Chairman and CEO of Parexel, said, "Combined with the existing post-approval and regulatory strengths of Parexel, this acquisition will support the expansion of our pharmacovigilance services onto a broader platform.  We are excited to be able to offer our clients QSI's leading services through our Clinical Research Services business​."

The QSI business will be integrated into Parexel's Peri/Post-Approval Services group which is part of the CRS (Clinical Research Services) segment.  It is also expected to synergies with the company’s Regulatory Outsourcing Services business.

The acquisition comes as Parexel recently expanded its site network​ to speed drug delivery, as well as acquired UK-based RTSM (Randomization and Trial Supply Management) company ClinIntel​.

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Related suppliers

Follow us


View more